Osteocalcin, growth, and inhaled corticosteroids: A prospective study

Archives of Disease in Childhood

Volumn 74, Issue 6, 1996, Pages 497-501

  Doull, Iolo ^a,b   Freezer, Nicholas ^a   Holgate, Stephen ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

growth; inhaled coticosteroids; osteocalcin

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; OSTEOCALCIN;

ARTICLE; ASTHMA; BONE GROWTH; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE TIME EFFECT RELATION; FEMALE; GROWTH INHIBITION; GROWTH RETARDATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 0029679825     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.74.6.497     Document Type: Article

References (28)

1. Spock A. Growth patterns in 200 children with bronchial asthma. Ann Allergy 1965; 23: 608-15.
2. Ruegsegger P, Medici TC, Anliker M. Corticosteroid induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25: 615-20.
3. Adinoff AD, Hollister JR. Steroid induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265-8.
4. Littlewood JM, Johnson AW, Edwards PA, Littlewood AE. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet 1988; i: 116-7.
5. Jennings BH, Andersson KE, Johansson SA. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991; 40: 77-82.
6. Pouw EM, Prummel MF, Oosting H, Roos CM, Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 1991; 302: 627-8.
7. Teelucksingh S, Padfield PL, Tibi L, Gough KJ, Holt PR. Inhaled corticosteroids, bone formation, and osteocalcin. Lancet 1991; 338: 60-1.
8. Meeran K, Hattersley A, Burrin J, Shiner R, Ibbertson K. Oral and inhaled corticosteroids suppress bone formation. Am Rev Respir Dis 1991; 143(4,pt2):abst 625.
9. Puolijoki H, Liippo K, Herrala J, Salmi J, Risteli J, Tala E. Does high dose inhaled beclomethasone (BDP) effect the calcium metabolism. Eur Respir J 1991; 4(suppl 14):483s.
10. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991; 88: 572-80.
11. Hodsman AB, Toogood JH, Jennings B, Fraher LJ, Baskerville JC. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 1991; 72: 530-40.
12. Price PA, Otsuka AS, Poser JW, Kristaponis J, Raman N. Characterization of a carboxyglutamic acid containing protein from bone. Biochemistry 1976; 73: 1447-51.
13. Cole DEC, Carpenter DO, Gundberg CM. Serum osteocalcin concentrations in children with metabolic bone disease. J Pediatr 1985; 106: 770-6.
14. Delmas PD, Chatelain P, Malaval L, Bonne G. Serum bone GLA-protein in growth hormone deficient children. J Bone Miner Res 1986; 1: 333-8.
15. Johansen JS, Jensen SB, Riis BJ, Ramussen L, Zachman M, Christiansen C. Serum bone GLA protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab 1990; 71: 122-6.
16. Kanzaki S, Hosoda K, Moriwake T, et al. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992; 175: 1104-9.
17. Eastell R, Hampton L, Colwell A, Green JR, Assiri AM, Hemp R. Urinary crosslinks are highly correlated with radioisotopic measurements one resorption. In: Christiansen C, Overgaard K, eds. Osteoporosis 1990. Osteopress, 1990:469-70.
18. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christioansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991; 6: 639-44.
19. Doull IJM, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995; 151: 1715-9.
20. Voss LD, Bailey BJR, Cumming K, Wilkin TJ, Berts PR. The reliability of height measurement (the Wessex growth study). Arch Dis Child 1990; 65: 1340-4.
21. Delmas PD. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med 1991; 91(suppl 5B):59S-63S.
22. Rossignol B, Rossignol D, Petitclerc C. Improvement of creatinine measurement on RA-1000. Clin Biochem 1984; 17: 203-4 (abst).
23. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr Pulmonol 1993; 16: 341-6.
24. Michaelsen KF, Johansen JS, Samuelson G, Price PA, Christiansen C. Serum bone γ carboxyglutamic acid protein in a longitudinal study in infants: lower values in formula fed infants. Pediatr Res 1992; 31: 410-5.
25. Tanner JM. A history of the study of human growth. Cambridge: Cambridge University Press, 1981.
26. Thomsen K, Eriksen EF, Jorgsen JCR, Charles P, Mosekilde L. Seasonal variation of bone GLA protein. Scand J Clin Invest 1989; 49: 605-11.
27. König P, Hillman L, Cervantes C, et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 1993; 122: 219-26.
28. Sorva R, Turpeinen M, Junmnen-Backman K, Karonen SL, Sorva A. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 1992; 90: 808-15.